Found: 20
Select item for more details and to access through your institution.
Quality of Life Associated with Ramucirumab Treatment in Patients with Advanced Gastric Cancer in Japan: Exploratory Analysis from the Phase III RAINBOW Trial.
- Published in:
- Clinical Drug Investigation, 2021, v. 41, n. 1, p. 53, doi. 10.1007/s40261-020-00979-3
- By:
- Publication type:
- Article
Real-World Outcomes and Factors Associated With the Second-Line Treatment of Patients With Gastric, Gastroesophageal Junction, or Esophageal Adenocarcinoma.
- Published in:
- Cancer Control: Journal of the Moffitt Cancer Center, 2019, v. 26, n. 1, p. N.PAG, doi. 10.1177/1073274819847642
- By:
- Publication type:
- Article
Real-World Outcomes and Factors Associated With the Second-Line Treatment of Patients With Gastric, Gastroesophageal Junction, or Esophageal Adenocarcinoma.
- Published in:
- 2019
- By:
- Publication type:
- journal article
Clinical management patterns of advanced and metastatic gastro‐oesophageal carcinoma after fluoropyrimidine/platinum treatment in France, Germany, Spain and the United Kingdom.
- Published in:
- European Journal of Cancer Care, 2020, v. 29, n. 2, p. 1, doi. 10.1111/ecc.13213
- By:
- Publication type:
- Article
Real-World Molecular Biomarker Testing Patterns and Results for Advanced Gastroesophageal Cancers in the United States.
- Published in:
- Current Oncology, 2023, v. 30, n. 2, p. 1869, doi. 10.3390/curroncol30020145
- By:
- Publication type:
- Article
Predictors of heterogeneity in the first-line treatment of patients with advanced/metastatic gastric cancer in the U.S.
- Published in:
- Gastric Cancer, 2018, v. 21, n. 5, p. 738, doi. 10.1007/s10120-018-0802-5
- By:
- Publication type:
- Article
Ramucirumab for the treatment of patients with gastric or gastroesophageal junction cancer in community oncology practices.
- Published in:
- Gastric Cancer, 2018, v. 21, n. 5, p. 831, doi. 10.1007/s10120-018-0796-z
- By:
- Publication type:
- Article
A comprehensive review of nongenetic prognostic and predictive factors influencing the heterogeneity of outcomes in advanced non-small-cell lung cancer.
- Published in:
- Cancer Management & Research, 2014, v. 6, p. 437, doi. 10.2147/CMAR.S63603
- By:
- Publication type:
- Article
Toward a Treatment Sequencing Strategy: A Systematic Review of Treatment Regimens in Advanced Gastric Cancer/Gastroesophageal Junction Adenocarcinoma.
- Published in:
- Oncologist, 2021, v. 26, n. 10, p. e1704, doi. 10.1002/onco.13907
- By:
- Publication type:
- Article
Early Weight Loss as a Prognostic Factor in Patients with Advanced Gastric Cancer: Analyses from REGARD, RAINBOW, and RAINFALL Phase III Studies.
- Published in:
- Oncologist, 2021, v. 26, n. 9, p. e1538, doi. 10.1002/onco.13836
- By:
- Publication type:
- Article
Tumor Response and Symptom Palliation from RAINBOW, a Phase III Trial of Ramucirumab Plus Paclitaxel in Previously Treated Advanced Gastric Cancer.
- Published in:
- Oncologist, 2021, v. 26, n. 3, p. e414, doi. 10.1002/onco.13623
- By:
- Publication type:
- Article
Health-related quality of life in the randomized phase 3 study of ramucirumab plus docetaxel versus placebo plus docetaxel in platinum-refractory advanced urothelial carcinoma (RANGE).
- Published in:
- 2020
- By:
- Publication type:
- journal article
Recommendations for including multiple symptoms as endpoints in cancer clinical trials.
- Published in:
- Cancer (0008543X), 2013, v. 119, n. 2, p. 411, doi. 10.1002/cncr.27744
- By:
- Publication type:
- Article
Treatment patterns in patients with advanced gastric cancer in Taiwan.
- Published in:
- Asia Pacific Journal of Clinical Oncology, 2017, v. 13, n. 3, p. 185, doi. 10.1111/ajco.12497
- By:
- Publication type:
- Article
Prognostic Factor Analysis of Overall Survival in Gastric Cancer from Two Phase III Studies of Second-line Ramucirumab (REGARD and RAINBOW) Using Pooled Patient Data.
- Published in:
- Journal of Gastric Cancer, 2017, v. 17, n. 2, p. 132, doi. 10.5230/jgc.2017.17.e16
- By:
- Publication type:
- Article
Treatment Patterns, Costs, and Survival among Medicare-Enrolled Elderly Patients Diagnosed with Advanced Stage Gastric Cancer: Analysis of a Linked Population-Based Cancer Registry and Administrative Claims Database.
- Published in:
- Journal of Gastric Cancer, 2015, v. 15, n. 2, p. 87, doi. 10.5230/jgc.2015.15.2.87
- By:
- Publication type:
- Article
Hepatocellular carcinoma after prior sorafenib treatment: incidence, healthcare utilisation and costs from German statutory health insurance claims data.
- Published in:
- Health Economics Review, 2018, v. 8, n. 1, p. 1, doi. 10.1186/s13561-018-0199-1
- By:
- Publication type:
- Article
Reliability of Conclusions from Early Analyses of Real-World Data for Newly Approved Drugs in Advanced Gastric Cancer in the United States.
- Published in:
- Pragmatic & Observational Research, 2020, v. 11, p. 27, doi. 10.2147/POR.S241427
- By:
- Publication type:
- Article
Patient-reported pain and other quality of life domains as prognostic factors for survival in a phase III clinical trial of patients with advanced breast cancer.
- Published in:
- 2016
- By:
- Publication type:
- journal article
Adapting the Lung Cancer Symptom Scale (LCSS) to mesothelioma: Using the LCSS‐meso conceptual model for validation.
- Published in:
- Cancer (0008543X), 2004, v. 101, n. 3, p. 587
- By:
- Publication type:
- Article